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There is no ideal tissue or substance to be injected in 
the vocal folds. The objective of the present study was to 
assess the use of Durasphere in canine vocal fold injection. 
Materials and Methods: in six adult dogs we injected 0.3 
mL of Durasphere in the middle third of the thyroarytenoid 
muscle and 0.3 mL of saline solution in the contralateral 
vocal fold. The animals were slaughtered after seven days 
(three dogs) and after 90 days (three dogs). We analyzed 
the inflammatory process in the vocal fold and in the lamina 
propria of the vocal folds. Results: in the vocal muscle 
which received Durasphere there was a significantly more 
intense inflammation when compared to the control muscle 
- there was a moderate lymphomodular infiltrate after seven 
days and mild after 90 days. We did not observe foreign 
bodies nor granulomas. On the lamina propria there was 
a mild inflammatory process in the two groups, without 
difference between them. Conclusion: this is a substance 
of proven biocompatibility in humans, with preliminary and 
unprecedented results and its injection in canine vocal folds 
caused a moderate inflammatory process after seven days 
and mild after 90 days, without foreign bodies or granuloma 
formation.
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INTRODUCTION
Normal laryngeal functioning requires the vocal 
folds to come close to each other for phonation and 
protection of the lower airways. When this reunion fails 
because of paralysis, atrophy or vocal fold fibrosis, glottal 
insufficiency ensues1,2,3. Patients unable to properly clo-
se their glottis can suffer of weak and blowy voice and 
chronic aspiration3.
Vocal fold injection is the technique used to correct 
this problem. The most commonly used substances to push 
the vocal folds medially are: Teflon, gelfoam, autogenous 
fat, collagen and autologous fascia1,4,5.
There is no ideal tissue universally accepted to inject 
in the vocal fold, and each material has its pros and cons. 
One new substance, Durasphere (Carbon Medical Tech-
nologies, St. Paul, Minnesota), made of pyrolithic carbon 
particles, suspended in aqueous gel6 was approved by 
the FDA (Food and Drug Administration) to treat urinary 
incontinence. Its function is to promote a closure (bulging) 
when injected in the submucosa of the urethra near the 
bladder neck, thus reestablishing bladder competence.
The ideal injectable substance must be biocom-
patible, durable, non-migratory, little immunogenic, of 
easy injection and which does not alter the viscoelastic 
properties of the vocal fold7. Considering that Durasphere 
has potential advantages which can be ideal for vocal fold 
injection, the goal of the present study was to assess the 
use of Durasphere as a substance to inject in canine vocal 
folds to treat glottic insufficiency.
MATERIALS AND METHODS
This study was approved by the Ethics Committee 
for Research Project Analysis - CAPPesq of the Clinical Bo-
ard of the University of São Paulo Medical School Hospital 
(protocol # 353/04).
In this study we used adult dogs, of both genders, 
from the research animal’s center of the Medical School 
of the University of São Paulo, without a defined race and 
mean weight of 10 kg.
Durasphere (Carbon Medical Technologies, St. Paul, 
Minnesota) is made of globules coated by pyrolithic carbon 
suspended in aqueous gel at 2.8% glucan (Figure 1). The 
particles have sizes which vary between 251 and 300µm.
With the animal in supine position and previously 
sedated, we carried out a suspension laryngoscopy to 
expose the animal’s glottis. Under light microscopy we 
injected 0.3mL of Durasphere in the middle third of the 
right vocal fold, lateral to the vocal process, at about 3mm 
of depth in the thyroarytenoid muscle, using a 19 gauge 
needle. The left vocal fold was used as control, and was 
injected with 0.3mL of 0.9% saline solution in the same 
site compared to the other fold.
The animals were slaughtered after 7 days (3 dogs) 
and 90 days (3 dogs) and submitted to total laryngectomy 
with dissection of all the structures adjacent to the larynx. 
We separated the two vocal folds and obtained a five 
millimeters thick fragment from the middle third of the 
intermembranous portion of each vocal fold, involving 
epithelium, lamina propria and vocal muscle. Durasphere 
- appeared as a well outlined mass of pasty consistency 
- was carefully removed from the vocal fold in order to 
facilitate the paraffin bloc cutting, because the results 
from the prior pilot study with five dogs showed that af-
ter paraffin impregnation, Durasphere became very hard, 
making it difficult to cut the paraffin with the microtome, 
and this caused muscle tissue laceration, impairing histo-
logical evaluation.
The vocal folds were fixed in 10% formaldehyde, 
dehydrated in 95% ethylic alcohol, cleared with xylol, im-
pregnated by paraffin melted in a 60 degree oven and after 
that they were cut with the microtome at a 5um thickness.
The slides were dyed with hematoxylin eosin. We 
analyzed the quantity and type of local inflammatory in-
filtrate in the vocal muscle and the lamina propria of both 
vocal folds, for that we used a quantitative and qualitative 
method.
The inflammatory process was qualitatively graded 
in mild, moderate or severe, based in the infiltrate intensi-
ty. We also noticed foreign body reaction and granuloma 
formation.
For the quantitative analysis in order to assess the 
quantity of the inflammatory reaction we chose 10 visual 
fields at random from the vocal muscle slide and 10 of the 
lamina propria with optical magnification of 400 times, on 
top of which we placed a squared grid with 10 vertical and 
10 horizontal lines, making up a total of 100 points of inter-
section. The points were counted in two groups: coinciding 
points which had inflammatory cells and inclusion points 
corresponding to the rest of the points. The inflammatory 
Figure 1. Durasphere in a 1mL syringe.
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process of each region was measured through an average 
of the coinciding points of the 10 fields analyzed (Figure 
2). We compared the inflammation percentages between 
the right (Durasphere) and left (control) vocal folds, and 
we grouped the dogs from the two groups (7 days and 90 
days), because of the small sample of our study. We used 
the Wilcoxon non-parametric test for paired samples, with 
a 5% significance level.
mation was significantly greater than that in the control 
muscle. In the lamina propria there was no difference 
regarding the inflammatory process between the two vocal 
folds (Chart 1).
Figure 2. Coronal histological cross-section of the canine right vocal 
fold from dog slaughtered after 90 days. Dye: hematoxylin-eosin. 
Quantitative analysis of the inflammatory process. Squared grid with 
10 vertical and 10 horizontal lines, making up a total of 100 points of 
intersection. The points were counted in two groups: coinciding points 
(PC) which had inflammatory cells and inclusion points (IP) correspon-
ding to the remaining points. The inflammatory process of each region 
was measured by means of an average value of the coinciding points 
of the 10 fields analyzed (400x).
RESULTS
We did not notice intraoperative or late complica-
tions in the animals of this study. In two animals there was 
a mild extrusion of the substance at the time of injection 
in the vocal muscle.
In the macroscopic inspection of the larynx we 
observed a bulging in the vocal fold with Durasphere after 
7 days and after 90 days. We did not see Durasphere in 
other laryngeal regions.
In the histologic analysis of the slides we noticed 
that the space previously occupied by Durasphere was 
empty (Figure 3). There was moderate lymphomononu-
clear infiltrate adjacent to this space in the vocal muscle 
within 7 days and a mild infiltrate after 90 days (Figure 4). 
There were no foreign bodies or granulomas.
In the lamina propria of the vocal folds with Du-
rasphere and the control ones we noticed a mild lympho-
mononuclear infiltrate with 7 days and 90 days (Figure 5).
The quantitative study of the inflammatory process 
revealed that in the vocal fold with Durasphere the inflam-
Figure 3. Coronal histological cross-section of the right vocal fold of a 
dog slaughtered after 90 days. Dye: hematoxylin-eosin. We notice an 
empty space in the vocal fold after removal of the Durasphere (50x).
Figure 4. Coronal histological cross-section of the right vocal fold 
(Durasphere) from a dog slaughtered after 90 days. Dye: hematoxylin-
eosin. We notice a mild lymphomononuclear infiltrate in the vocal 
muscle adjacent to the empty space (200x).
Chart 1. Quantitative analysis of the inflammatory process in 6 dogs 
(p <0.05)
% Inflammation
RVF (Durasphere)
N = 6
LVF (control)
N = 6
p
Lamina propria 7,0 ± 2,4 5,8 ± 3,0 0,6
Muscle 9,5 ± 8,4 0,9 ± 0,8 0,046
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DISCUSSION
Durasphere has been clinically used in the submu-
cosa of tissues (urethra or anal sphincter); however, its use 
in the larynx to treat glottic insufficiency has never been 
attempted, and this motivated this initial study in dogs.
Durasphere injected in the vocal muscle of dogs 
showed a moderate inflammatory reaction, one significan-
tly greater than that in the control muscle, and such result 
was expected since it is a synthetic substance. Synthetic 
particles like teflon8 can cause an intense inflammatory 
process; however, Durasphere in the vocal muscle did 
not cause an intense inflammatory process, foreign body 
reaction or granulomas.
Durasphere was initially tested as injection substan-
ce in the periurethral tissue of dogs in order to establish its 
biocompatibility and migration potential. In assessments 
held up to 2 years there was mild to moderate inflamma-
tory process from 7 to 28 days, which evolved to chronic 
mild inflammatory process in the periods of 3, 6, 12 and 
24 months, involving the build up of macrophages9.
Human biocompatibility has been proven in clinical 
practice. Lightner et al.6 did a multicentric, randomized, 
controlled and double-blinded study with Durasphere and 
bovine collagen as injection substances for the treatment 
of stress urinary incontinence in 355 women between 26 
and 84 years. Results during the 1 year follow up revea-
led that Durasphere is a safe substance and an effective 
alternative for the treatment of urinary incontinence, whi-
ch was in agreement with other studies10,11. Durasphere 
effectiveness has also been proven in the treatment of 
fecal incontinence12.
Synthetic substances can migrate to other tissues. 
Prior studies8,13 suggest that particles larger than 50µm have 
a lower likelihood of migration. Although our study did 
not assess a possible lymphatic migration when injected 
in the vocal fold, an experimental study in dogs9 showed 
that when injected in the periurethral tissue there was 
no migration to the lymphatic tissue. We believe that the 
same happens when it is injected in the vocal fold. The 
low migration risk can be due to the fact that Durasphere 
is made up of larger particles ( 251 and 300µm).
Resorption is also a problem associated with the in-
jection of substances. This study did not assess objectively 
a possible Durasphere resorption; however, the evaluation 
after 3 months showed the presence of Durasphere in all 
the dogs and since it is a synthetic substance, the like-
lihood of resorption is lower. A study7 with hydroxyapatite 
reveals the possible need for reinjections because of the 
absorption of the aqueous gel which carries the particles, 
this may also happen with Durasphere.
In our study, Durasphere was injected in the vocal 
muscle and despite the substance being made up of lar-
ger particles (251 to 300µm), there was no resistance to 
its injection, probably because the quantity injected was 
small, 0.3mL, while in the urethra, where the injection is 
in the submucosa, the quantity is much higher, 4.8mL in 
average6. We inject it in the vocal fold because it does not 
alter its viscoelastic properties, keeping the histologic cha-
racteristics of the lamina propria intact, added to the fact 
that there was no significant inflammatory process in the 
lamina propria when compared to the control vocal fold.
CONCLUSION
This is a substance of proven biocompatibility in 
humans, with preliminary and unprecedented results from 
its injection in canine vocal folds, which caused a moderate 
inflammatory process after 7 days and mild one after 90 
days, without foreign body or granuloma reactions. 
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